In this podcast, Professor Maria Victoria Mateos, Consultant Physician at the Haematology Department at the University Hospital of Salamanca, describes her experience with bortezomib in the elderly population and how novel agents have changed the treatment paradigm and goals for transplant ineligible patients. She also explains how formal frailty scales can be useful when assessing chronologically older patients, particularly when they are assessed by younger clinicians.

This podcast was sponsored by Janssen. The content is based on published studies and the opinions of independent experts. The views expressed are not necessarily those of Janssen.

PLEASE REVIEW PRODUCT INFORMATION BEFORE PRESCRIBING (available from www.janssen.com.au).